Review




Structured Review

Millipore recombinant human albumin
( A , B ) Representative residual clots at the clot lysis assay endpoint (60 minutes) from pDTR -nephrotic rat plasmas supplemented with <t>recombinant</t> Albumin ( A ) or Ovalbumin ( B ) ( shows representative residual clots of unmanipulated samples). ( C ) Lysis, expressed as a percentage of rat PNP values, is corrected by rAlbumin, but not Ovalbumin, supplementation. WT: wild-type; DT: diphtheria toxin; pDTR : podocin-promoter driven diphtheria toxin receptor transgene; rAlbumin: recombinant albumin; OvA: ovalbumin (note: OvA is a serpin-family, not an albumin-family, protein); n=5-8 rats/group; * P <0.05, ** P <0.01, *** P <0.001.
Recombinant Human Albumin, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human albumin/product/Millipore
Average 90 stars, based on 1 article reviews
recombinant human albumin - by Bioz Stars, 2026-02
90/100 stars

Images

1) Product Images from "Hypoalbuminemia Increases Fibrin Clot Density and Impairs Fibrinolysis"

Article Title: Hypoalbuminemia Increases Fibrin Clot Density and Impairs Fibrinolysis

Journal: bioRxiv

doi: 10.1101/2025.02.03.635731

( A , B ) Representative residual clots at the clot lysis assay endpoint (60 minutes) from pDTR -nephrotic rat plasmas supplemented with recombinant Albumin ( A ) or Ovalbumin ( B ) ( shows representative residual clots of unmanipulated samples). ( C ) Lysis, expressed as a percentage of rat PNP values, is corrected by rAlbumin, but not Ovalbumin, supplementation. WT: wild-type; DT: diphtheria toxin; pDTR : podocin-promoter driven diphtheria toxin receptor transgene; rAlbumin: recombinant albumin; OvA: ovalbumin (note: OvA is a serpin-family, not an albumin-family, protein); n=5-8 rats/group; * P <0.05, ** P <0.01, *** P <0.001.
Figure Legend Snippet: ( A , B ) Representative residual clots at the clot lysis assay endpoint (60 minutes) from pDTR -nephrotic rat plasmas supplemented with recombinant Albumin ( A ) or Ovalbumin ( B ) ( shows representative residual clots of unmanipulated samples). ( C ) Lysis, expressed as a percentage of rat PNP values, is corrected by rAlbumin, but not Ovalbumin, supplementation. WT: wild-type; DT: diphtheria toxin; pDTR : podocin-promoter driven diphtheria toxin receptor transgene; rAlbumin: recombinant albumin; OvA: ovalbumin (note: OvA is a serpin-family, not an albumin-family, protein); n=5-8 rats/group; * P <0.05, ** P <0.01, *** P <0.001.

Techniques Used: Lysis, Recombinant

( A ) Representative photomicrographs of clots formed from 1 st and 4 th albumin IQR pDTR -rat plasma (as in ) with Ovalbumin or rAlbumin supplementation. ( B ) Fibrin area. ( C ) Fibrin network density. ( D ) Fibrin clot porosity. IQR: interquartile range; WT: wild-type; DT: diphtheria toxin; pDTR : podocin-promoter driven diphtheria toxin receptor transgene; rAlbumin: recombinant human albumin; OvA: ovalbumin (note: OvA is a serpin-family, not an albumin-family, protein); n=8 rats/group; * P <0.05, ** P <0.01, *** P <0.001.
Figure Legend Snippet: ( A ) Representative photomicrographs of clots formed from 1 st and 4 th albumin IQR pDTR -rat plasma (as in ) with Ovalbumin or rAlbumin supplementation. ( B ) Fibrin area. ( C ) Fibrin network density. ( D ) Fibrin clot porosity. IQR: interquartile range; WT: wild-type; DT: diphtheria toxin; pDTR : podocin-promoter driven diphtheria toxin receptor transgene; rAlbumin: recombinant human albumin; OvA: ovalbumin (note: OvA is a serpin-family, not an albumin-family, protein); n=8 rats/group; * P <0.05, ** P <0.01, *** P <0.001.

Techniques Used: Clinical Proteomics, Recombinant

( A ) Representative residual clots at the clot lysis assay endpoint (60 minutes) from albumin knockout rat plasmas (as in ) without and with recombinant Albumin (rAlbumin) supplementation. ( B ) Lysis, expressed as a percentage of rat PNP values, was diminished in homozygous and heterozygous albumin knockout rat clots and was corrected by rAlbumin supplementation. ( C ) Representative photomicrographs of clots formed from albumin knockout rat plasmas without and with rAlbumin supplementation. ( D ) Fibrin area. ( E ) Fibrin network density. ( F ) Fibrin clot porosity. rAlbumin: recombinant albumin; n=5 rats/group; *** P <0.001.
Figure Legend Snippet: ( A ) Representative residual clots at the clot lysis assay endpoint (60 minutes) from albumin knockout rat plasmas (as in ) without and with recombinant Albumin (rAlbumin) supplementation. ( B ) Lysis, expressed as a percentage of rat PNP values, was diminished in homozygous and heterozygous albumin knockout rat clots and was corrected by rAlbumin supplementation. ( C ) Representative photomicrographs of clots formed from albumin knockout rat plasmas without and with rAlbumin supplementation. ( D ) Fibrin area. ( E ) Fibrin network density. ( F ) Fibrin clot porosity. rAlbumin: recombinant albumin; n=5 rats/group; *** P <0.001.

Techniques Used: Lysis, Knock-Out, Recombinant



Similar Products

92
MedChemExpress recombinant human soluble tweak
Recombinant Human Soluble Tweak, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human soluble tweak/product/MedChemExpress
Average 92 stars, based on 1 article reviews
recombinant human soluble tweak - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

99
New England Biolabs recombinant human albumin
Recombinant Human Albumin, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human albumin/product/New England Biolabs
Average 99 stars, based on 1 article reviews
recombinant human albumin - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
New England Biolabs b9200s recombinant human h2a
B9200s Recombinant Human H2a, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b9200s recombinant human h2a/product/New England Biolabs
Average 99 stars, based on 1 article reviews
b9200s recombinant human h2a - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

90
Sangon Biotech recombinant human serum albumin (hsa)
Recombinant Human Serum Albumin (Hsa), supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human serum albumin (hsa)/product/Sangon Biotech
Average 90 stars, based on 1 article reviews
recombinant human serum albumin (hsa) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Nacalai recombinant human serum albumin
Recombinant Human Serum Albumin, supplied by Nacalai, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human serum albumin/product/Nacalai
Average 90 stars, based on 1 article reviews
recombinant human serum albumin - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

96
Boster Bio w v bovine serum albumin bsa
W V Bovine Serum Albumin Bsa, supplied by Boster Bio, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/w v bovine serum albumin bsa/product/Boster Bio
Average 96 stars, based on 1 article reviews
w v bovine serum albumin bsa - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

90
WUHAN HEALTHGEN BIOTECHNOLOGY CORP recombinant human serum albumin (hsa)
Recombinant Human Serum Albumin (Hsa), supplied by WUHAN HEALTHGEN BIOTECHNOLOGY CORP, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human serum albumin (hsa)/product/WUHAN HEALTHGEN BIOTECHNOLOGY CORP
Average 90 stars, based on 1 article reviews
recombinant human serum albumin (hsa) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Millipore recombinant human albumin
( A , B ) Representative residual clots at the clot lysis assay endpoint (60 minutes) from pDTR -nephrotic rat plasmas supplemented with <t>recombinant</t> Albumin ( A ) or Ovalbumin ( B ) ( shows representative residual clots of unmanipulated samples). ( C ) Lysis, expressed as a percentage of rat PNP values, is corrected by rAlbumin, but not Ovalbumin, supplementation. WT: wild-type; DT: diphtheria toxin; pDTR : podocin-promoter driven diphtheria toxin receptor transgene; rAlbumin: recombinant albumin; OvA: ovalbumin (note: OvA is a serpin-family, not an albumin-family, protein); n=5-8 rats/group; * P <0.05, ** P <0.01, *** P <0.001.
Recombinant Human Albumin, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human albumin/product/Millipore
Average 90 stars, based on 1 article reviews
recombinant human albumin - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Biozym Inc human recombinant il-1β, in pbs with 1% human or bovine serum albumin
( A , B ) Representative residual clots at the clot lysis assay endpoint (60 minutes) from pDTR -nephrotic rat plasmas supplemented with <t>recombinant</t> Albumin ( A ) or Ovalbumin ( B ) ( shows representative residual clots of unmanipulated samples). ( C ) Lysis, expressed as a percentage of rat PNP values, is corrected by rAlbumin, but not Ovalbumin, supplementation. WT: wild-type; DT: diphtheria toxin; pDTR : podocin-promoter driven diphtheria toxin receptor transgene; rAlbumin: recombinant albumin; OvA: ovalbumin (note: OvA is a serpin-family, not an albumin-family, protein); n=5-8 rats/group; * P <0.05, ** P <0.01, *** P <0.001.
Human Recombinant Il 1β, In Pbs With 1% Human Or Bovine Serum Albumin, supplied by Biozym Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human recombinant il-1β, in pbs with 1% human or bovine serum albumin/product/Biozym Inc
Average 90 stars, based on 1 article reviews
human recombinant il-1β, in pbs with 1% human or bovine serum albumin - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


( A , B ) Representative residual clots at the clot lysis assay endpoint (60 minutes) from pDTR -nephrotic rat plasmas supplemented with recombinant Albumin ( A ) or Ovalbumin ( B ) ( shows representative residual clots of unmanipulated samples). ( C ) Lysis, expressed as a percentage of rat PNP values, is corrected by rAlbumin, but not Ovalbumin, supplementation. WT: wild-type; DT: diphtheria toxin; pDTR : podocin-promoter driven diphtheria toxin receptor transgene; rAlbumin: recombinant albumin; OvA: ovalbumin (note: OvA is a serpin-family, not an albumin-family, protein); n=5-8 rats/group; * P <0.05, ** P <0.01, *** P <0.001.

Journal: bioRxiv

Article Title: Hypoalbuminemia Increases Fibrin Clot Density and Impairs Fibrinolysis

doi: 10.1101/2025.02.03.635731

Figure Lengend Snippet: ( A , B ) Representative residual clots at the clot lysis assay endpoint (60 minutes) from pDTR -nephrotic rat plasmas supplemented with recombinant Albumin ( A ) or Ovalbumin ( B ) ( shows representative residual clots of unmanipulated samples). ( C ) Lysis, expressed as a percentage of rat PNP values, is corrected by rAlbumin, but not Ovalbumin, supplementation. WT: wild-type; DT: diphtheria toxin; pDTR : podocin-promoter driven diphtheria toxin receptor transgene; rAlbumin: recombinant albumin; OvA: ovalbumin (note: OvA is a serpin-family, not an albumin-family, protein); n=5-8 rats/group; * P <0.05, ** P <0.01, *** P <0.001.

Article Snippet: In other experiments, CLA was performed with tissue-type plasminogen activator (tPA; 20 nM) or plasmin (1.2 μM) in lieu of uPA or after immunodepleting or supplementing specific proteins, as indicated – most notably, recombinant human albumin (expressed in P. pastoris ; Millipore Sigma).

Techniques: Lysis, Recombinant

( A ) Representative photomicrographs of clots formed from 1 st and 4 th albumin IQR pDTR -rat plasma (as in ) with Ovalbumin or rAlbumin supplementation. ( B ) Fibrin area. ( C ) Fibrin network density. ( D ) Fibrin clot porosity. IQR: interquartile range; WT: wild-type; DT: diphtheria toxin; pDTR : podocin-promoter driven diphtheria toxin receptor transgene; rAlbumin: recombinant human albumin; OvA: ovalbumin (note: OvA is a serpin-family, not an albumin-family, protein); n=8 rats/group; * P <0.05, ** P <0.01, *** P <0.001.

Journal: bioRxiv

Article Title: Hypoalbuminemia Increases Fibrin Clot Density and Impairs Fibrinolysis

doi: 10.1101/2025.02.03.635731

Figure Lengend Snippet: ( A ) Representative photomicrographs of clots formed from 1 st and 4 th albumin IQR pDTR -rat plasma (as in ) with Ovalbumin or rAlbumin supplementation. ( B ) Fibrin area. ( C ) Fibrin network density. ( D ) Fibrin clot porosity. IQR: interquartile range; WT: wild-type; DT: diphtheria toxin; pDTR : podocin-promoter driven diphtheria toxin receptor transgene; rAlbumin: recombinant human albumin; OvA: ovalbumin (note: OvA is a serpin-family, not an albumin-family, protein); n=8 rats/group; * P <0.05, ** P <0.01, *** P <0.001.

Article Snippet: In other experiments, CLA was performed with tissue-type plasminogen activator (tPA; 20 nM) or plasmin (1.2 μM) in lieu of uPA or after immunodepleting or supplementing specific proteins, as indicated – most notably, recombinant human albumin (expressed in P. pastoris ; Millipore Sigma).

Techniques: Clinical Proteomics, Recombinant

( A ) Representative residual clots at the clot lysis assay endpoint (60 minutes) from albumin knockout rat plasmas (as in ) without and with recombinant Albumin (rAlbumin) supplementation. ( B ) Lysis, expressed as a percentage of rat PNP values, was diminished in homozygous and heterozygous albumin knockout rat clots and was corrected by rAlbumin supplementation. ( C ) Representative photomicrographs of clots formed from albumin knockout rat plasmas without and with rAlbumin supplementation. ( D ) Fibrin area. ( E ) Fibrin network density. ( F ) Fibrin clot porosity. rAlbumin: recombinant albumin; n=5 rats/group; *** P <0.001.

Journal: bioRxiv

Article Title: Hypoalbuminemia Increases Fibrin Clot Density and Impairs Fibrinolysis

doi: 10.1101/2025.02.03.635731

Figure Lengend Snippet: ( A ) Representative residual clots at the clot lysis assay endpoint (60 minutes) from albumin knockout rat plasmas (as in ) without and with recombinant Albumin (rAlbumin) supplementation. ( B ) Lysis, expressed as a percentage of rat PNP values, was diminished in homozygous and heterozygous albumin knockout rat clots and was corrected by rAlbumin supplementation. ( C ) Representative photomicrographs of clots formed from albumin knockout rat plasmas without and with rAlbumin supplementation. ( D ) Fibrin area. ( E ) Fibrin network density. ( F ) Fibrin clot porosity. rAlbumin: recombinant albumin; n=5 rats/group; *** P <0.001.

Article Snippet: In other experiments, CLA was performed with tissue-type plasminogen activator (tPA; 20 nM) or plasmin (1.2 μM) in lieu of uPA or after immunodepleting or supplementing specific proteins, as indicated – most notably, recombinant human albumin (expressed in P. pastoris ; Millipore Sigma).

Techniques: Lysis, Knock-Out, Recombinant